These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Prevention of postoperative venous thromboembolism in Japanese patients undergoing total hip or knee arthroplasty: two randomized, double-blind, placebo-controlled studies with three dosage regimens of enoxaparin. Fuji T, Ochi T, Niwa S, Fujita S. J Orthop Sci; 2008 Sep; 13(5):442-51. PubMed ID: 18843459 [Abstract] [Full Text] [Related]
5. Low-molecular-weight heparin (enoxaparin) as prophylaxis against venous thromboembolism after total hip replacement. Bergqvist D, Benoni G, Björgell O, Fredin H, Hedlundh U, Nicolas S, Nilsson P, Nylander G. N Engl J Med; 1996 Sep 05; 335(10):696-700. PubMed ID: 8703168 [Abstract] [Full Text] [Related]
10. Oral dabigatran versus enoxaparin for thromboprophylaxis after primary total hip arthroplasty (RE-NOVATE II*). A randomised, double-blind, non-inferiority trial. Eriksson BI, Dahl OE, Huo MH, Kurth AA, Hantel S, Hermansson K, Schnee JM, Friedman RJ, RE-NOVATE II Study Group. Thromb Haemost; 2011 Apr 05; 105(4):721-9. PubMed ID: 21225098 [Abstract] [Full Text] [Related]
11. Dalteparin for prevention of catheter-related complications in cancer patients with central venous catheters: final results of a double-blind, placebo-controlled phase III trial. Karthaus M, Kretzschmar A, Kröning H, Biakhov M, Irwin D, Marschner N, Slabber C, Fountzilas G, Garin A, Abecasis NG, Baronius W, Steger GG, Südhoff T, Giorgetti C, Reichardt P. Ann Oncol; 2006 Feb 05; 17(2):289-96. PubMed ID: 16317012 [Abstract] [Full Text] [Related]
13. A pilot randomized double-blind comparison of a low-molecular-weight heparin, a nonsteroidal anti-inflammatory agent, and placebo in the treatment of superficial vein thrombosis. Superficial Thrombophlebitis Treated By Enoxaparin Study Group. Arch Intern Med; 2003 Jul 28; 163(14):1657-63. PubMed ID: 12885680 [Abstract] [Full Text] [Related]
14. A comparison of enoxaparin with placebo for the prevention of venous thromboembolism in acutely ill medical patients. Prophylaxis in Medical Patients with Enoxaparin Study Group. Samama MM, Cohen AT, Darmon JY, Desjardins L, Eldor A, Janbon C, Leizorovicz A, Nguyen H, Olsson CG, Turpie AG, Weisslinger N. N Engl J Med; 1999 Sep 09; 341(11):793-800. PubMed ID: 10477777 [Abstract] [Full Text] [Related]
15. [Venous thromboembolism associated with long-term use of central venous catheters in cancer patients]. Debourdeau P, Chahmi DK, Zammit C, Farge-Bancel D. Pathol Biol (Paris); 2008 Jun 09; 56(4):211-9. PubMed ID: 18395994 [Abstract] [Full Text] [Related]
16. Efficacy and safety of bemiparin compared with enoxaparin in the prevention of venous thromboembolism after total knee arthroplasty: a randomized, double-blind clinical trial. Navarro-Quilis A, Castellet E, Rocha E, Paz-Jiménez J, Planès A, Bemiparin Study Group in Knee Arthroplasty. J Thromb Haemost; 2003 Mar 09; 1(3):425-32. PubMed ID: 12871445 [Abstract] [Full Text] [Related]
18. Efficacy and safety of postdischarge administration of enoxaparin in the prevention of deep venous thrombosis after total hip replacement. A prospective randomised double-blind placebo-controlled trial. Planes A, Vochelle N, Darmon JY, Fagola M, Bellaud M, Compan D, Saliba E, Weisslinger N, Huet Y. Drugs; 1996 Mar 09; 52 Suppl 7():47-54. PubMed ID: 9042560 [Abstract] [Full Text] [Related]
19. Local versus central assessment of venographies in a multicenter trial on the prevention of deep vein thrombosis in neurosurgery. Rossi R, Agnelli G, Taborelli P, Fioroni C, Zerbi D, Pattacini P, Giugni E, Bagatella P, Vaccarino A. Thromb Haemost; 1999 Nov 09; 82(5):1399-402. PubMed ID: 10595626 [Abstract] [Full Text] [Related]
20. A synthetic pentasaccharide for the prevention of deep-vein thrombosis after total hip replacement. Turpie AG, Gallus AS, Hoek JA, Pentasaccharide Investigators. N Engl J Med; 2001 Mar 01; 344(9):619-25. PubMed ID: 11228275 [Abstract] [Full Text] [Related] Page: [Next] [New Search]